Total Funding
70
81
Total FundingPost-IPO Debt raised
Growth Score
-19 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
14822
ICON is a global provider of outsourced drug development services to biopharma, medical device, biosimilar and generic organizations.
- Roxy Bicknell: Talent Acquisition Business PartnerPast Role: Maetrics, Corporate Recruiter
Michael Forstner: Senior Director Patient SafetyPast Role: Medicines for Europe, Co-chair, Pharmacovigilance Working Group
About the Company
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies.
